NKTR

Conviction 47HealthcareScan · Thu, Jun 25, 2026

NKTR$62.04-4.32%

ResistanceSupportVol 14Insider sell

Vol MA14 994.63K

Mar 26Apr 14May 1May 19Jun 8Jun 25

NEKTAR THERAPEUTICSPHARMACEUTICAL PREPARATIONSwww.nektar.com ↗

Price62.04

Change-4.32%

Gap+1.02%

Rel volume2.46×

Avg volume1.03M

Avg $ vol62.83M

SMA 2060.95

SMA 5072.84

SMA 20061.29

Price vs 50-14.83%

Price vs 200+1.22%

MA stackmixed

50/200 cross—

Supertrendup · 56.29

RSI (14)44

MACD hist1.29

MACD crossbull · 8d

Stoch %K / %D57 / 76

ADX (14)31

+DI / −DI20 / 24

RSI divergence—

MACD divergenceBullish

ATR %+5.51%

ADR %4.90%

52w high100.35

52w low21.68

From 52w high-38.18%

Above 52w low+186.16%

New 52w highNo

SqueezeOff

Bollinger width20.81%

%B0.59

Donchian pos57.19%

Donchian high67.96

Donchian low54.13

AVWAP (52w high)75.90

vs AVWAP high-18.26%

AVWAP (52w low)59.49

vs AVWAP low+4.28%

OBV trendDown

Chaikin MF (20)-0.13

Today vs 20d2.46×

Avg vol (14d)994.63K

Avg vol (20d)1.03M

Avg $ vol (20d)62.83M

Market cap2.1B

RS 3m (vs SPY)-23.39%

RS 6m (vs SPY)+30.69%

RS line new highNo

Trend template4/8

Technical rank49.0

1 week+1.84%

1 month-5.37%

3 months-13.93%

6 months+42.69%

1 year+153.74%

YTD+42.88%

P/E-12.78

P/B3.64

P/S37.95

P/FCF-10.04

EPS-9.73

Div yield—

ROE-28.47%

ROA-21.50%

Debt/Eq0.23

Current10.21

EV/EBITDA-15.29

Gross margin1.13%

Net margin-297.07%

Rev growth-43.89%

EPS growth-37.92%

Price target154.33

Target upside148.76%

Analyst ratingBuy

Institutional83.34%

Ent. value2.08B

Revenue10.86M

Net income-44.9M

Gross profit—

Free cash flow-208.68M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out33.79M

Employees63

ListedTue, May 3, 1994

Free float28.9M

Float %97.4%

Short interest4.61M

Days to cover5.3d

Short volume51.0%

Squeeze score79 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$2.05 · 7 est

Last EPS vs est−$1.82 vs −$1.74

Last surprise-4.6% miss

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank49.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance78.98

Support55.98

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NKTR

All disclosures →

No recent disclosed trades by Congress in NKTR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NKTR · 6 sells

Insider	Side	Shares	Value	Traded	Filed
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-17	Sell	4.5K	$277K	2026-06-17	2026-06-18
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-17	Sell	5.5K	$334K	2026-06-17	2026-06-18
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-16	Sell	5.3K	$318K	2026-06-16	2026-06-18
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-16	Sell	4.7K	$285K	2026-06-16	2026-06-18
Zalevsky Jonathan Chief R&D Officer · Common Stock · 2026-05-19	Sell	199	$13K	2026-05-19	2026-05-21
ROBIN HOWARD W President & CEO · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
ROBIN HOWARD W President & CEO · Common Stock · 2026-05-19	Sell	444	$29K	2026-05-19	2026-05-21

SEC filings

EDGAR filings in NKTR · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.